Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device

Standard

Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device. / Boriani, Giuseppe; Palmisano, Pietro; Malavasi, Vincenzo Livio; Fantecchi, Elisa; Vitolo, Marco; Bonini, Niccolo'; Imberti, Jacopo F; Valenti, Anna Chiara; Schnabel, Renate B; Freedman, Ben.

In: J CLIN MED, Vol. 10, No. 4, 729, 12.02.2021.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Boriani, G, Palmisano, P, Malavasi, VL, Fantecchi, E, Vitolo, M, Bonini, N, Imberti, JF, Valenti, AC, Schnabel, RB & Freedman, B 2021, 'Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device', J CLIN MED, vol. 10, no. 4, 729. https://doi.org/10.3390/jcm10040729

APA

Boriani, G., Palmisano, P., Malavasi, V. L., Fantecchi, E., Vitolo, M., Bonini, N., Imberti, J. F., Valenti, A. C., Schnabel, R. B., & Freedman, B. (2021). Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device. J CLIN MED, 10(4), [729]. https://doi.org/10.3390/jcm10040729

Vancouver

Bibtex

@article{f68d43dbe0594409af7e8ad1f2abb0fe,
title = "Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device",
abstract = "Our aim was to assess the prevalence of unknown atrial fibrillation (AF) among adults during single-time point rhythm screening performed during meetings or social recreational activities organized by patient groups or volunteers. A total of 2814 subjects (median age 68 years) underwent AF screening by a handheld single-lead ECG device (MyDiagnostick). Overall, 56 subjects (2.0%) were diagnosed with AF, as a result of 12-lead ECG following a positive/suspected recording. Screening identified AF in 2.9% of the subjects ≥ 65 years. None of the 265 subjects aged below 50 years was found positive at AF screening. Risk stratification for unknown AF based on a CHA2DS2VASc > 0 in males and >1 in females (or CHA2DS2VA > 0) had a high sensitivity (98.2%) and a high negative predictive value (99.8%) for AF detection. A slightly lower sensitivity (96.4%) was achieved by using age ≥ 65 years as a risk stratifier. Conversely, raising the threshold at ≥75 years showed a low sensitivity. Within the subset of subjects aged ≥ 65 a CHA2DS2VASc > 1 in males and >2 in females, or a CHA2DS2VA > 1 had a high sensitivity (94.4%) and negative predictive value (99.3%), while age ≥ 75 was associated with a marked drop in sensitivity for AF detection.",
author = "Giuseppe Boriani and Pietro Palmisano and Malavasi, {Vincenzo Livio} and Elisa Fantecchi and Marco Vitolo and Niccolo' Bonini and Imberti, {Jacopo F} and Valenti, {Anna Chiara} and Schnabel, {Renate B} and Ben Freedman",
year = "2021",
month = feb,
day = "12",
doi = "10.3390/jcm10040729",
language = "English",
volume = "10",
journal = "J CLIN MED",
issn = "2077-0383",
publisher = "MDPI AG",
number = "4",

}

RIS

TY - JOUR

T1 - Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device

AU - Boriani, Giuseppe

AU - Palmisano, Pietro

AU - Malavasi, Vincenzo Livio

AU - Fantecchi, Elisa

AU - Vitolo, Marco

AU - Bonini, Niccolo'

AU - Imberti, Jacopo F

AU - Valenti, Anna Chiara

AU - Schnabel, Renate B

AU - Freedman, Ben

PY - 2021/2/12

Y1 - 2021/2/12

N2 - Our aim was to assess the prevalence of unknown atrial fibrillation (AF) among adults during single-time point rhythm screening performed during meetings or social recreational activities organized by patient groups or volunteers. A total of 2814 subjects (median age 68 years) underwent AF screening by a handheld single-lead ECG device (MyDiagnostick). Overall, 56 subjects (2.0%) were diagnosed with AF, as a result of 12-lead ECG following a positive/suspected recording. Screening identified AF in 2.9% of the subjects ≥ 65 years. None of the 265 subjects aged below 50 years was found positive at AF screening. Risk stratification for unknown AF based on a CHA2DS2VASc > 0 in males and >1 in females (or CHA2DS2VA > 0) had a high sensitivity (98.2%) and a high negative predictive value (99.8%) for AF detection. A slightly lower sensitivity (96.4%) was achieved by using age ≥ 65 years as a risk stratifier. Conversely, raising the threshold at ≥75 years showed a low sensitivity. Within the subset of subjects aged ≥ 65 a CHA2DS2VASc > 1 in males and >2 in females, or a CHA2DS2VA > 1 had a high sensitivity (94.4%) and negative predictive value (99.3%), while age ≥ 75 was associated with a marked drop in sensitivity for AF detection.

AB - Our aim was to assess the prevalence of unknown atrial fibrillation (AF) among adults during single-time point rhythm screening performed during meetings or social recreational activities organized by patient groups or volunteers. A total of 2814 subjects (median age 68 years) underwent AF screening by a handheld single-lead ECG device (MyDiagnostick). Overall, 56 subjects (2.0%) were diagnosed with AF, as a result of 12-lead ECG following a positive/suspected recording. Screening identified AF in 2.9% of the subjects ≥ 65 years. None of the 265 subjects aged below 50 years was found positive at AF screening. Risk stratification for unknown AF based on a CHA2DS2VASc > 0 in males and >1 in females (or CHA2DS2VA > 0) had a high sensitivity (98.2%) and a high negative predictive value (99.8%) for AF detection. A slightly lower sensitivity (96.4%) was achieved by using age ≥ 65 years as a risk stratifier. Conversely, raising the threshold at ≥75 years showed a low sensitivity. Within the subset of subjects aged ≥ 65 a CHA2DS2VASc > 1 in males and >2 in females, or a CHA2DS2VA > 1 had a high sensitivity (94.4%) and negative predictive value (99.3%), while age ≥ 75 was associated with a marked drop in sensitivity for AF detection.

U2 - 10.3390/jcm10040729

DO - 10.3390/jcm10040729

M3 - SCORING: Journal article

C2 - 33673209

VL - 10

JO - J CLIN MED

JF - J CLIN MED

SN - 2077-0383

IS - 4

M1 - 729

ER -